Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1543725

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1543725

Global Home Respiratory Therapy Market Size Study, by Product Type, by Application (Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, Others), by Age Group and Regional Forecasts 2022-2032

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

Global Home Respiratory Therapy Market is valued at approximately USD 8.55 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.72% over the forecast period 2024-2032. Home respiratory therapy provides essential medical support to individuals with chronic respiratory conditions within the comfort of their own homes. This encompasses a variety of services including oxygen therapy, nebulizer treatments, and ventilator care, all designed to enhance breathing and overall quality of life. Health professionals such as respiratory therapists play a crucial role in assessing and monitoring patients, ensuring the proper use of equipment, and adherence to treatment plans. This form of therapy promotes independence, minimizes hospital visits, and delivers personalized care, thereby improving comfort and convenience for patients managing respiratory diseases.

The growth trajectory of the home respiratory therapy market is driven by several pivotal factors. The rapidly expanding geriatric population, coupled with increased healthcare spending and advancements in the healthcare sector, significantly bolster the demand for home care therapy products. Additionally, heightened awareness about respiratory diseases and the surging need for oxygen therapy further propel market growth. The oxygen therapy segment, in particular, accounts for the highest growth within the market, reflecting its critical role in respiratory care.

Regionally, North America commands the largest share of the home respiratory therapy market, a dominance attributed to the growing geriatric population and rising incidences of respiratory disorders within the region. Europe follows closely, driven by increased awareness about home respiratory therapy. The Asia Pacific region is poised to be the fastest-growing market during the forecast period, spurred by rising per capita income and significant investments by key market players in the healthcare sector. This regional growth is indicative of the burgeoning demand for home respiratory therapy across diverse demographics.

Major market players included in this report are:

  • Genesis Rehab Services
  • West River Health Services
  • Fisher & Paykel Healthcare Limited
  • Medtronic plc
  • Drager Safety AG & Co. KGaA
  • ResMed, Inc.
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • AstraZeneca Plc
  • F Hoffman-La Roche Ltd
  • Philips Healthcare
  • Invacare Corporation
  • GE Healthcare
  • Drive DeVilbiss Healthcare
  • Chart Industries, Inc.

The detailed segments and sub-segment of the market are explained below:

By Product Type:

  • Respiratory Care Devices
  • Respiratory Care Services
  • Respiratory Care Drugs

By Application:

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Cystic Fibrosis
  • Others

By Age Group:

  • Pediatrics
  • Adults
  • Geriatrics

By Region:

North America:

  • U.S.
  • Canada

Europe:

  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE

Asia Pacific:

  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC

Latin America:

  • Brazil
  • Mexico
  • RoLA

Middle East & Africa:

  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Home Respiratory Therapy Market Executive Summary

  • 1.1. Global Home Respiratory Therapy Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product Type
    • 1.3.2. By Application
    • 1.3.3. By Age Group
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Home Respiratory Therapy Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Home Respiratory Therapy Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rapidly Growing Geriatric Population
    • 3.1.2. Increased Healthcare Spending
    • 3.1.3. Advances in the Healthcare Sector
  • 3.2. Market Challenges
    • 3.2.1. High Costs of Home Respiratory Therapy
    • 3.2.2. Limited Awareness in Developing Regions
  • 3.3. Market Opportunities
    • 3.3.1. Growing Demand for Home Care Therapy Products
    • 3.3.2. Increased Awareness about Respiratory Diseases
    • 3.3.3. Technological Advancements in Respiratory Care

Chapter 4. Global Home Respiratory Therapy Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Home Respiratory Therapy Market Size & Forecasts by Product Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Home Respiratory Therapy Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Respiratory Care Devices
    • 5.2.2. Respiratory Care Services
    • 5.2.3. Respiratory Care Drugs

Chapter 6. Global Home Respiratory Therapy Market Size & Forecasts by Application 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Home Respiratory Therapy Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Chronic Obstructive Pulmonary Disease (COPD)
    • 6.2.2. Asthma
    • 6.2.3. Cystic Fibrosis
    • 6.2.4. Others

Chapter 7. Global Home Respiratory Therapy Market Size & Forecasts by Age Group 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Home Respiratory Therapy Market: Age Group Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. Pediatrics
    • 7.2.2. Adults
    • 7.2.3. Geriatrics

Chapter 8. Global Home Respiratory Therapy Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Home Respiratory Therapy Market
    • 8.1.1. U.S. Home Respiratory Therapy Market
      • 8.1.1.1. Product Type breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Application breakdown size & forecasts, 2022-2032
      • 8.1.1.3. Age Group breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Home Respiratory Therapy Market
  • 8.2. Europe Home Respiratory Therapy Market
    • 8.2.1. UK Home Respiratory Therapy Market
    • 8.2.2. Germany Home Respiratory Therapy Market
    • 8.2.3. France Home Respiratory Therapy Market
    • 8.2.4. Spain Home Respiratory Therapy Market
    • 8.2.5. Italy Home Respiratory Therapy Market
    • 8.2.6. Rest of Europe Home Respiratory Therapy Market
  • 8.3. Asia-Pacific Home Respiratory Therapy Market
    • 8.3.1. China Home Respiratory Therapy Market
    • 8.3.2. India Home Respiratory Therapy Market
    • 8.3.3. Japan Home Respiratory Therapy Market
    • 8.3.4. Australia Home Respiratory Therapy Market
    • 8.3.5. South Korea Home Respiratory Therapy Market
    • 8.3.6. Rest of Asia Pacific Home Respiratory Therapy Market
  • 8.4. Latin America Home Respiratory Therapy Market
    • 8.4.1. Brazil Home Respiratory Therapy Market
    • 8.4.2. Mexico Home Respiratory Therapy Market
    • 8.4.3. Rest of Latin America Home Respiratory Therapy Market
  • 8.5. Middle East & Africa Home Respiratory Therapy Market
    • 8.5.1. Saudi Arabia Home Respiratory Therapy Market
    • 8.5.2. South Africa Home Respiratory Therapy Market
    • 8.5.3. Rest of Middle East & Africa Home Respiratory Therapy Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Genesis Rehab Services
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. West River Health Services
    • 9.3.3. Fisher & Paykel Healthcare Limited
    • 9.3.4. Medtronic plc
    • 9.3.5. Drager Safety AG & Co. KGaA
    • 9.3.6. ResMed, Inc.
    • 9.3.7. GlaxoSmithKline Plc
    • 9.3.8. Merck & Co Inc
    • 9.3.9. AstraZeneca Plc
    • 9.3.10. F Hoffman-La Roche Ltd
    • 9.3.11. Philips Healthcare
    • 9.3.12. Invacare Corporation
    • 9.3.13. GE Healthcare
    • 9.3.14. Drive DeVilbiss Healthcare
    • 9.3.15. Chart Industries, Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!